Both TBL1X and the closely related gene TBLR1 have been implicated in the activation of the Wnt/beta-catenin signaling pathway, which has been reported to be overactivated in the progression and proliferation of several tumors, including breast tumors, where it has been linked with reduced overall survival [48–50]. Here, TBL1X is linked to breast neoplasm.